GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
Remdesivir was the first drug approved by the Food and Drug Administration to treat COVID-19. Gilead Sciences, Inc., originally developed it to treat other viral diseases.
We reviewed federal contributions to development of remdesivir and related agency patent rights.
As of Dec.
This report updates our oversight of federal actions to support public health, individuals, and the economy during the COVID-19 pandemic. Findings include:
There have been shortages of personal protective equipment and testing supplies because very few of them are made in the U.S.
We make more than 1,000 recommendations annually to help improve government. We alert department heads to the recommendations that can save the most money, address issues on our High Risk List, or significantly improve their operations.
U.S. laboratories working with dangerous biological pathogens (commonly referred to as high-containment laboratories) have proliferated in recent years. As a result, the public is concerned about the oversight of these laboratories.